Perspectives on cancer therapy-induced mucosal injury

Cancer - Tập 100 Số S9 - Trang 1995-2025 - 2004
Stephen T. Sonis1,2, Linda S. Elting3,4, Dorothy Keefe5,6, Douglas E. Peterson7,8, Mark M. Schubert9,10, Martin Hauer‐Jensen11, B. Nebiyou Bekele3, Judith E. Raber‐Durlacher12, J. Peter Donnelly13, Edward Rubenstein14,15,16,17
1Division of Oral Medicine, Brigham & Women's Hospital, Boston, Massachusetts
2Dr. Sonis has served as a consultant for Biomodels and Affiliates, LLC (Wellesley, MA).
3Department of Biostatistics and Applied Mathematics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
4Dr. Elting has received speaker's honoraria from McNeill Pharmaceuticals and Endo Pharmaceuticals (Chadds Ford, PA).
5Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
6Dr. Keefe has received research funding and speaker's honoraria from Amgen.
7Department of Oral Diagnosis, University of Connecticut Health Center, Farmington, Connecticut
8Dr. Peterson has served as a paid consultant for Aesgen, Inc. (Princeton, NJ).
9Department of Oral Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington
10Dr. Schubert is a member of the Advisory Boards for Endo Pharmaceuticals, OSI Pharmaceuticals, and McNeill Pharmaceuticals and has received consulting fees per meeting plus expenses.
11Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas
12Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
13Department of Hematology, Nijmegen University Hospital, Nijmegen, The Netherlands
14Department of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
15Dr. Rubenstein has received research funding from and is a member of the speakers program and advisory board at Merck (Whitehouse Station, NJ)
16he is a member of the advisory boards at Endo Pharmaceuticals, McNeil Consumer and Specialty Pharmaceuticals, and OSI Pharmaceuticals.
17he owns common stock in and is a member of the advisory board at MGI Pharma

Tóm tắt

Từ khóa


Tài liệu tham khảo

Elting, 2003, Cancer, 98, 1531, 10.1002/cncr.11671

Rubenstein, 2004, Cancer, 100, 2026, 10.1002/cncr.20163

Lockhart, 1981, J Dermatol Surg Oncol, 7, 1019, 10.1111/j.1524-4725.1981.tb00208.x

Sonis, 2000, Oral Oncol, 36, 373, 10.1016/S1368-8375(00)00012-9

Paris, 2001, Science, 293, 293, 10.1126/science.1060191

Handschel, 1999, Int J Radiat Oncol Biol Phys, 45, 475, 10.1016/S0360-3016(99)00202-3

Wang, 2002, Thromb Haemost, 87, 122, 10.1055/s-0037-1612954

Hall, 1995, Exp Hematol, 23, 1256

Epstein, 2001, Cancer, 92, 875, 10.1002/1097-0142(20010815)92:4<875::AID-CNCR1396>3.0.CO;2-1

Gate, 1999, Biomed Pharmacother, 53, 169, 10.1016/S0753-3322(99)80086-9

Culy, 2001, Drugs, 61, 641, 10.2165/00003495-200161050-00012

Maddens, 2002, Blood, 100, 1294, 10.1182/blood.V100.4.1294.h81602001294_1294_1301

Handschel, 2001, J Pathol, 193, 242, 10.1002/1096-9896(2000)9999:9999<::AID-PATH754>3.0.CO;2-P

Zheng, 2000, Radiat Res, 153, 533, 10.1667/0033-7587(2000)153[0533:ROMCIE]2.0.CO;2

Dorr, 2002, Cell Prolif, 35, 60, 10.1046/j.1365-2184.35.s1.6.x

Ulrich, 2001, Blood, 98, 231, 10.1182/blood.V98.1.231

Sonis, 2002, Crit Rev Oral Biol Med, 13, 380, 10.1177/154411130201300502

Carratu, 1998, Oncol Rep, 5, 635

Hovdenak, 2000, J Radiat Oncol Biol Phys, 48, 1111, 10.1016/S0360-3016(00)00744-6

Alimentary tract radiation pathology. Oxford: Oxford University Press, 2001: 208-247.

Mechanisms and modification of the radiation response of gastrointestinal organs. In: editors. Biological modification of radiation response. Heidelberg: Springer Verlag, 2003: 49-72.

Ijiri, 1983, Br J Cancer, 47, 175, 10.1038/bjc.1983.25

Ijiri, 1987, Br J Cancer, 55, 113, 10.1038/bjc.1987.25

Keefe, 2000, Gut, 47, 632, 10.1136/gut.47.5.632

Daniele, 2001, Gut, 48, 28, 10.1136/gut.48.1.28

Gibson, 2002, Dig Dis Sci, 47, 2751, 10.1023/A:1021061306913

The effect of cytotoxic chemotherapy on the mucosa of the small intestine. Adelaide, South Australia: University of Adelaide, 1998.

Pritchard, 1998, Cancer Res, 58, 5453

Gibson, 2002, Cancer Chemother Pharmacol, 50, 53, 10.1007/s00280-002-0460-4

The expression of the Bcl-2 family members in the small and large intestine. Adelaide, South Australia: Department of Medicine Adelaide, University of Adelaide, 2001.

Gibson, 2003, Gastroenterol Hepatol, 18, 1095, 10.1046/j.1440-1746.2003.03136.x

Squier, 2001, J Natl Cancer Inst Monogr, 29, 7, 10.1093/oxfordjournals.jncimonographs.a003443

Sartori, 1996, Cancer, 78, 1477, 10.1002/(SICI)1097-0142(19961001)78:7<1477::AID-CNCR15>3.0.CO;2-X

Sartori, 2000, J Clin Oncol, 18, 463, 10.1200/JCO.2000.18.3.463

Ibrahim, 2002, Cancer Invest, 20, 29, 10.1081/CNV-120000363

Dosik, 1979, Am J Med, 67, 646, 10.1016/0002-9343(79)90248-1

Keidan, 1989, Dis Colon Rectum, 32, 206, 10.1007/BF02554529

Cardenal, 1996, J Natl Cancer Inst, 88, 1078, 10.1093/jnci/88.15.1078

Pestalozzi, 1993, Cancer, 71, 1797, 10.1002/1097-0142(19930301)71:5<1797::AID-CNCR2820710514>3.0.CO;2-B

Trotti, 2000, Int J Radiat Oncol Biol Phys, 47, 13, 10.1016/S0360-3016(99)00559-3

National Cancer Institute. Cancer Therapy Evaluation Program forms and templates: Generic CTC version 2.0. Data collection form. Available from URL: http://ctep.cancer.gov/forms/ctc_genatacol.pdf [accessed June 15, 2003].

World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva: World Health Organization, 1979.

Radiation Therapy Oncology Group. Acute radiation morbidity scoring criteria. Available from URL: http://www.rtog.org/members/toxicity/acute.htm, n.d. [accessed June 15, 2003].

Schubert, 1992, Cancer, 69, 2469, 10.1002/1097-0142(19920515)69:10<2469::AID-CNCR2820691015>3.0.CO;2-W

McGuire, 2002, Cancer Invest, 20, 893, 10.1081/CNV-120005902

Sonis, 1999, Cancer, 85, 2103, 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0

Spijkervet, 1989, J Oral Pathol Med, 18, 167, 10.1111/j.1600-0714.1989.tb00756.x

Eilers, 1988, Oncol Nurs Forum, 15, 325

1991, Cancer Nurs, 14, 6

Walsh, 1999, Spec Care Dentist, 10, 190, 10.1111/j.1754-4505.1990.tb00795.x

Tardieu, 1996, Eur J Cancer B Oral Oncol, 32B, 381, 10.1016/S0964-1955(96)00026-7

Donnelly, 1992, Bone Marrow Transplant, 9, 409

Dibble, 1996, Cancer Pract, 4, 135

Wymenga, 1997, Br J Cancer, 76, 1062, 10.1038/bjc.1997.508

Measurement of oral tissue damage and mucositis pain. New York: Raven Press, 1993.

Chapko, 1989, Bone Marrow Transplant, 4, 181

Keefe, 1997, Clin Sci (London), 92, 385, 10.1042/cs0920385

Berard, 1998, J Clin Epidemiol, 51, 801, 10.1016/S0895-4356(98)00073-0

An introduction to the bootstrap. New York: Chapman & Hall, 1993.

Zittoun, 1999, Psychooncology, 8, 64, 10.1002/(SICI)1099-1611(199901/02)8:1<64::AID-PON337>3.0.CO;2-R

Kelemen, 1998, Bone Marrow Transplant, 21, 747, 10.1038/sj.bmt.1701167

Yuen, 1998, Bone Marrow Transplant, 21, 1137, 10.1038/sj.bmt.1701246

Bush, 1995, Soc Sci Med, 40, 479, 10.1016/0277-9536(94)00153-K

Bellm, 2000, Support Care Cancer, 8, 33, 10.1007/s005209900095

Sonis, 2001, J Clin Oncol, 19, 2201, 10.1200/JCO.2001.19.8.2201

Ruescher, 1998, Cancer, 82, 2275, 10.1002/(SICI)1097-0142(19980601)82:11<2275::AID-CNCR25>3.0.CO;2-Q

Coghlin Dickson, 2000, JPEN J Parenter Enteral Nutr, 24, 61, 10.1177/014860710002400261

Mills, 1995, Leuk Lymphoma, 17, 263, 10.3109/10428199509056831

Atkinson, 1987, Bone Marrow Transplant, 2, 385

Wardley, 2000, Br J Haematol, 110, 292, 10.1046/j.1365-2141.2000.02202.x

Muus, 1993, Semin Oncol, 20, 47

Spitzer, 1989, Bone Marrow Transplant, 4, 559

Beelen, 1989, Blood, 74, 1507, 10.1182/blood.V74.5.1507.1507

Kroger, 1998, Bone Marrow Transplant, 22, 1029, 10.1038/sj.bmt.1701498

Kroger, 1998, Bone Marrow Transplant, 21, 1171, 10.1038/sj.bmt.1701245

Kleiner, 1997, Bone Marrow Transplant, 20, 953, 10.1038/sj.bmt.1701002

Lalisang, 1998, Bone Marrow Transplant, 21, 243, 10.1038/sj.bmt.1701071

Zander, 1997, Clin Cancer Res, 3, 2671

Desikan, 2000, Bone Marrow Transplant, 25, 483, 10.1038/sj.bmt.1702167

Chan, 1997, Bone Marrow Transplant, 20, 1039, 10.1038/sj.bmt.1701014

Gutierrez-Delgado, 2000, Prog Proc Am Soc Clin Oncol, 19, 14a

Belanger, 2000, Prog Proc Am Soc Clin Oncol, 19, 33a

Fernandez, 2000, Prog Proc Am Soc Clin Oncol, 19, 132a

Martinez-Aguillo, 2000, Prog Proc Am Soc Clin Oncol, 19, 563a

Tiersten, 2001, Prog Proc Am Soc Clin Oncol, 20, 183b

Sullivan, 2001, Prog Proc Am Soc Clin Oncol, 20, 14a

Sun, 2001, Prog Proc Am Soc Clin Oncol, 20, 206b

Ozkaynak, 1998, J Clin Oncol, 16, 937, 10.1200/JCO.1998.16.3.937

Gordon, 1997, Bone Marrow Transplant, 20, 5, 10.1038/sj.bmt.1700827

Gordon, 1992, Blood, 80, 2938, 10.1182/blood.V80.11.2938.2938

Rubin, 1996, Bone Marrow Transplant, 18, 533

McCowage, 1995, J Clin Oncol, 13, 2789, 10.1200/JCO.1995.13.11.2789

Borgmann, 1994, Klin Padiatr, 206, 299, 10.1055/s-2008-1046618

Tubergen, 1995, J Clin Oncol, 13, 1368, 10.1200/JCO.1995.13.6.1368

Gaynon, 1988, Am J Pediatr Hematol Oncol, 10, 42, 10.1097/00043426-198821000-00009

Pein, 1993, J Clin Oncol, 11, 1478, 10.1200/JCO.1993.11.8.1478

Buckley, 1989, Med Pediatr Oncol, 17, 382, 10.1002/mpo.2950170507

Kelly, 2002, Ann Oncol, 13, 107, 10.1093/annonc/13.S1.107

Nachman, 2002, J Clin Oncol, 20, 3765, 10.1200/JCO.2002.12.007

Philip, 1999, Ann Oncol, 10, 1065, 10.1023/A:1008395126800

Grovas, 1999, Med Pediatr Oncol, 33, 83, 10.1002/(SICI)1096-911X(199908)33:2<83::AID-MPO4>3.0.CO;2-G

Ortega, 2000, J Clin Oncol, 18, 2665, 10.1200/JCO.2000.18.14.2665

O'Brien, 2002, Blood, 100, 2708, 10.1182/blood.V100.8.2708

Lange, 2002, Blood, 99, 825, 10.1182/blood.V99.3.825

Kreissman, 1997, J Pediatr Hematol Oncol, 19, 309, 10.1097/00043426-199707000-00008

Nitschke, 1998, J Pediatr Hematol Oncol, 20, 315, 10.1097/00043426-199807000-00006

Chan, 1996, J Pediatr Hematol Oncol, 18, 63, 10.1097/00043426-199602000-00012

Furman, 2002, J Clin Oncol, 20, 1617, 10.1200/JCO.2002.20.6.1617

Ogden, 2002, J Pediatr Hematol Oncol, 24, 182, 10.1097/00043426-200203000-00005

Dahllof, 2001, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 92, 420, 10.1067/moe.2001.101804

Muller, 2000, Br J Haematol, 110, 379, 10.1046/j.1365-2141.2000.02187.x

Dahl, 2000, J Clin Oncol, 18, 1867, 10.1200/JCO.2000.18.9.1867

Godder, 2000, J Clin Oncol, 18, 1856, 10.1200/JCO.2000.18.9.1856

Mulne, 2000, J Pediatr Hematol Oncol, 22, 41, 10.1097/00043426-200001000-00008

Giona, 1997, Br J Haematol, 99, 671, 10.1046/j.1365-2141.1997.4413253.x

Pappo, 1997, J Pediatr Hematol Oncol, 19, 438, 10.1097/00043426-199709000-00006

Arndt, 1997, J Pediatr Hematol Oncol, 19, 124, 10.1097/00043426-199703000-00005

Bernstein, 1997, J Pediatr Hematol Oncol, 19, 68, 10.1097/00043426-199701000-00010

Locatelli, 1996, Br J Haematol, 92, 49, 10.1046/j.1365-2141.1996.00276.x

Bordigoni, 1998, Br J Haematol, 102, 656, 10.1046/j.1365-2141.1998.00825.x

Marco, 2000, J Clin Oncol, 18, 3256, 10.1200/JCO.2000.18.18.3256

Fleischhack, 1998, Br J Haematol, 102, 647, 10.1046/j.1365-2141.1998.00836.x

Ghim, 1998, J Pediatr Hematol Oncol, 20, 131, 10.1097/00043426-199803000-00008

Kletzel, 1998, J Pediatr Hematol Oncol, 20, 49, 10.1097/00043426-199801000-00008

Shapiro, 1999, Clin Cancer Res, 5, 2399

Herskovic, 2000, Cancer Invest, 18, 537, 10.3109/07357900009012193

Butler, 1999, Int J Radiat Oncol Biol Phys, 45, 21, 10.1016/S0360-3016(99)00101-7

Kohno, 2000, Gan To Kagaku Ryoho, 27, 592

Regazzoni, 1996, Ann Oncol, 7, 807, 10.1093/oxfordjournals.annonc.a010759

Focan, 1993, J Clin Oncol, 11, 1253, 10.1200/JCO.1993.11.7.1253

Bastholt, 1996, J Clin Oncol, 14, 1146, 10.1200/JCO.1996.14.4.1146

Levine, 1998, J Clin Oncol, 16, 2651, 10.1200/JCO.1998.16.8.2651

Brufman, 1997, Ann Oncol, 8, 155, 10.1023/A:1008295427877

Chu, 1996, J Infus Chemother, 6, 211

Dreizen, 1986, Oral Surg Oral Med Oral Pathol, 62, 650, 10.1016/0030-4220(86)90258-6

Culine, 1997, Am J Clin Oncol, 20, 184, 10.1097/00000421-199704000-00017

Pazdur, 1997, Oncology, 54, 19, 10.1159/000227741

Labianca, 1997, Ann Oncol, 8, 169, 10.1023/A:1008200713533

Guha-Thakurta, 1999, J Neurooncol, 43, 259, 10.1023/A:1006210703827

Barrett, 1987, Oral Surg Oral Med Oral Pathol, 63, 424, 10.1016/0030-4220(87)90253-2

Funke, 2000, Ann Hematol, 79, 132, 10.1007/s002770050568

Feldman, 1997, Leukemia, 11, 485, 10.1038/sj.leu.2400623

Popescu, 1999, J Clin Oncol, 17, 2412, 10.1200/JCO.1999.17.8.2412

Van Cutsem, 1999, Semin Oncol, 26, 13

Streit, 1997, Ann Oncol, 8, 163, 10.1023/A:1008257603687

Tsavaris, 1996, Am J Clin Oncol, 19, 517, 10.1097/00000421-199610000-00018

Caponigro, 1999, Cancer, 85, 952, 10.1002/(SICI)1097-0142(19990215)85:4<952::AID-CNCR25>3.0.CO;2-N

Bjordal, 1995, Eur J Cancer B Oral Oncol, 31B, 235, 10.1016/0964-1955(95)00010-F

Hammerlid, 1997, Oral Oncol, 33, 189, 10.1016/S0964-1955(96)00069-3

Epstein, 1999, Head Neck, 21, 1, 10.1002/(SICI)1097-0347(199901)21:1<1::AID-HED1>3.0.CO;2-4

Oliverio, 1999, J Chemother, 11, 301, 10.1179/joc.1999.11.4.301

Ohrn, 2001, Support Care Cancer, 9, 528, 10.1007/s005200100253

Chiara, 1998, Cancer Chemother Pharmacol, 42, 336, 10.1007/s002800050826

Mantovani, 1999, Oncol Rep, 6, 1425

Chougule, 1999, Semin Radiat Oncol, 9, 58

Vokes, 2000, J Clin Oncol, 18, 1652, 10.1200/JCO.2000.18.8.1652

van Putten, 2000, Br J Cancer, 82, 806, 10.1054/bjoc.1999.1003

Cobleigh, 1999, J Clin Oncol, 17, 2639, 10.1200/JCO.1999.17.9.2639

Bishop, 1999, J Clin Oncol, 17, 2355, 10.1200/JCO.1999.17.8.2355

Bishop, 1997, Oncology (Huntington), 11, 19

Bishop, 1997, Semin Oncol, 24, s17

Zaniboni, 1998, Cancer, 82, 2135, 10.1002/(SICI)1097-0142(19980601)82:11<2135::AID-CNCR7>3.0.CO;2-U

Dumphy, 1997, Semin Oncol, 24, s19

Zalcberg, 1997, Anticancer Drugs, 8, s17, 10.1097/00001813-199708002-00004

Cunningham, 1998, Br J Cancer, 77, 15, 10.1038/bjc.1998.421

Groener, 1999, Anticancer Drugs, 10, 283, 10.1097/00001813-199903000-00005

Dreizen, 1981, Postgrad Med, 69, 103, 10.1080/00325481.1981.11715676

Dillman, 1999, Cancer Metast Rev, 18, 465, 10.1023/A:1006341717398

Levy, 2001, J Clin Epidemiol, 54, 747, 10.1016/S0895-4356(00)00359-0

Keating, 2000, Semin Oncol, 27, 86

Itoh, 2002, Ann Oncol, 13, 1347, 10.1093/annonc/mdf287

Intragumtornchai, 2000, Clin Lymphoma, 1, 219, 10.3816/CLM.2000.n.018

Walewski, 2000, Med Oncol, 18, 141, 10.1385/MO:18:2:141

Coiffier, 2002, N Engl J Med, 346, 235, 10.1056/NEJMoa011795

Balzarotti, 2002, Ann Oncol, 13, 1341, 10.1093/annonc/mdf242

Gaynor, 2001, J Clin Oncol, 19, 750, 10.1200/JCO.2001.19.3.750

Vase, 2001, J Clin Oncol, 19, 389, 10.1200/JCO.2001.19.2.389

Czuczman, 1999, J Clin Oncol, 17, 268, 10.1200/JCO.1999.17.1.268

Czuczman, 1999, Semin Oncol, 26, 88

McLaughlin, 2000, Semin Oncol, 27, 37

Kantarjian, 2002, N Engl J Med, 346, 645, 10.1056/NEJMoa011573

Kantarjian, 2002, Blood, 99, 3547, 10.1182/blood.V99.10.3547

Sawyers, 2002, Blood, 99, 3530, 10.1182/blood.V99.10.3530

Talpaz, 2002, Blood, 99, 1928, 10.1182/blood.V99.6.1928

Di Costanzo, 1996, Am J Clin Oncol, 19, 307, 10.1097/00000421-199606000-00021

Wibault, 1996, J Clin Oncol, 14, 1192, 10.1200/JCO.1996.14.4.1192

Dragovic, 1995, Cancer, 76, 1655, 10.1002/1097-0142(19951101)76:9<1655::AID-CNCR2820760923>3.0.CO;2-Q

Cunningham, 1995, Eur J Cancer, 31A, 1945, 10.1016/0959-8049(95)00502-1

Hill, 1995, J Clin Oncol, 13, 2317, 10.1200/JCO.1995.13.9.2317

Sledge, 1995, Semin Oncol, 22, 105

Joss, 1995, Ann Oncol, 6, 41, 10.1093/oxfordjournals.annonc.a059039

Caudry, 1995, Am J Clin Oncol, 18, 118, 10.1097/00000421-199504000-00005

Pazdur, 1994, J Clin Oncol, 12, 2296, 10.1200/JCO.1994.12.11.2296

Zagonel, 1994, Ann Oncol, 5, 127, 10.1093/annonc/5.suppl_2.S127

Machover, 1993, Ann Oncol, 4, 29, 10.1093/annonc/4.suppl_2.S29

Wiernik, 1993, Leukemia, 7, 1236

Francini, 1993, Cancer Chemother Pharmacol, 32, 359, 10.1007/BF00735919

Anderson, 1993, Br J Cancer, 67, 1385, 10.1038/bjc.1993.256

Bundgaard, 1993, Int J Oral Maxillofac Surg, 22, 28, 10.1016/S0901-5027(05)80352-2

Machover, 1992, J Natl Cancer Inst, 84, 321, 10.1093/jnci/84.5.321

Cowan, 1991, J Natl Cancer Inst, 83, 1077, 10.1093/jnci/83.15.1077

Henderson, 1989, J Clin Oncol, 7, 560, 10.1200/JCO.1989.7.5.560

Bennett, 1988, J Clin Oncol, 6, 1611, 10.1200/JCO.1988.6.10.1611

Mattson, 1988, Semin Oncol, 15, 32

Kish, 1984, Cancer, 53, 1819, 10.1002/1097-0142(19840501)53:9<1819::AID-CNCR2820530903>3.0.CO;2-R

Hande, 1982, Am J Med, 73, 413, 10.1016/0002-9343(82)90745-8

Vaughn, 1981, Oncology, 38, 129, 10.1159/000225538

Buechler, 1979, Cancer, 43, 1095, 10.1002/1097-0142(197903)43:3<1095::AID-CNCR2820430347>3.0.CO;2-P

Lissoni, 1997, Ann Oncol, 8, 969, 10.1023/A:1008221310453

Younes, 1998, Br J Haematol, 103, 678, 10.1046/j.1365-2141.1998.01048.x

Blum, 2001, Cancer, 92, 1759, 10.1002/1097-0142(20011001)92:7<1759::AID-CNCR1691>3.0.CO;2-A

Saltz, 2000, N Engl J Med, 343, 905, 10.1056/NEJM200009283431302

Garuffi, 2001, Cancer, 91, 712, 10.1002/1097-0142(20010215)91:4<712::AID-CNCR1056>3.0.CO;2-4

Verschraegen, 1997, J Clin Oncol, 15, 625, 10.1200/JCO.1997.15.2.625

Markman, 2000, Gynecol Oncol, 78, 369, 10.1006/gyno.2000.5921

Gordon, 2000, J Clin Oncol, 18, 3093, 10.1200/JCO.2000.18.17.3093

Ibrahim, 1999, Cancer, 86, 1251, 10.1002/(SICI)1097-0142(19991001)86:7<1251::AID-CNCR21>3.0.CO;2-F

Colevas, 2000, Prog Proc Am Soc Clin Oncol, 19, 420a

Hesketh, 1999, Cancer J Sci Am, 5, 237

Verweij, 2000, J Clin Oncol, 18, 2081, 10.1200/JCO.2000.18.10.2081

von Minckwitz, 1999, J Clin Oncol, 17, 1999, 10.1200/JCO.1999.17.7.1999

Chan, 1999, J Clin Oncol, 17, 2341, 10.1200/JCO.1999.17.8.2341

Muggia, 1997, J Clin Oncol, 15, 987, 10.1200/JCO.1997.15.3.987

Cardoso, 2001, Anticancer Res, 21, 789

Kwasny, 2000, Breast Cancer Res Treat, 63, 235, 10.1023/A:1006421901192

Bennouna, 2000, Eur J Cancer, 36, 1107, 10.1016/S0959-8049(00)00097-6

Di Leo, 2000, Ann Oncol, 11, 169, 10.1023/A:1008345432342

Pazdur, 1999, Am J Clin Oncol, 22, 78, 10.1097/00000421-199902000-00019

Valero, 2000, Prog Proc Am Soc Clin Oncol, 19, 132a

Kavanagh, 1996, Clin Cancer Res, 2, 837

Couteau, 1999, Br J Cancer, 81, 457, 10.1038/sj.bjc.6690715

Viens, 2001, Am J Clin Oncol, 24, 328, 10.1097/00000421-200108000-00002

Alexandre, 2000, J Clin Oncol, 18, 562, 10.1200/JCO.2000.18.3.562

Iirillo, 2000, Prog Proc Am Soc Clin Oncol, 19, 281a

Beuzeboc, 2000, Prog Proc Am Soc Clin Oncol, 19, 150a

Picozzi, 2000, Prog Proc Am Soc Clin Oncol, 19, 267a

Mabro, 2000, Prog Proc Am Soc Clin Oncol, 19, 294a

Cvitkovic, 2000, Prog Proc Am Soc Clin Oncol, 19, 314a

Di Lauro, 2000, Prog Proc Am Soc Clin Oncol, 19, 273a

Calvo, 2000, Prog Proc Am Soc Clin Oncol, 19, 259a

Anchisi, 2000, Prog Proc Am Soc Clin Oncol, 19, 326a

Afonso-Afonso, 2000, Prog Proc Am Soc Clin Oncol, 19, 428a

Tassinari, 2000, Prog Proc Am Soc Clin Oncol, 19, 278a

Cascinu, 2000, Prog Proc Am Soc Clin Oncol, 19, 274a

Vazquez, 2000, Prog Proc Am Soc Clin Oncol, 19, 316a

Aranda, 2000, Prog Proc Am Soc Clin Oncol, 19, 324a

Guglielmi, 2000, Prog Proc Am Soc Clin Oncol, 19, 273a

Ravaioli, 2000, Prog Proc Am Soc Clin Oncol, 19, 278a

Maiello, 2000, Prog Proc Am Soc Clin Oncol, 19, 324a

Zaniboni, 2000, Prog Proc Am Soc Clin Oncol, 19, 304a

Mousseau, 2000, Prog Proc Am Soc Clin Oncol, 19, 233a

Droz, 2000, Prog Proc Am Soc Clin Oncol, 19, 359a

Shulman, 2000, Prog Proc Am Soc Clin Oncol, 19, 288a

Pastorelli, 2000, Prog Proc Am Soc Clin Oncol, 19, 284a

Tsalic, 2000, Prog Proc Am Soc Clin Oncol, 19, 269a

Adenis, 2000, Prog Proc Am Soc Clin Oncol, 19, 279a

Ducreux, 2000, Prog Proc Am Soc Clin Oncol, 19, 241a

Blackstock, 2000, Prog Proc Am Soc Clin Oncol, 19, 294a

Jabboury, 2000, Prog Proc Am Soc Clin Oncol, 19, 223a

Gray, 2000, Prog Proc Am Soc Clin Oncol, 19, 494a

Rana, 2000, Prog Proc Am Soc Clin Oncol, 19, 144a

Shamash, 2000, Prog Proc Am Soc Clin Oncol, 19, 371a

Tumolo, 2000, Prog Proc Am Soc Clin Oncol, 19, 407a

Lopez, 2000, Prog Proc Am Soc Clin Oncol, 19, 141a

Von Minckwitz, 2000, Prog Proc Am Soc Clin Oncol, 19, 120a

Kroger, 2000, Prog Proc Am Soc Clin Oncol, 19, 12a

Biganzonli, 2000, Prog Proc Am Soc Clin Oncol, 19, 73a

Cohen, 2000, Prog Proc Am Soc Clin Oncol, 19, 15a

Jones, 2000, Prog Proc Am Soc Clin Oncol, 19, 116a

Tirelli, 2000, Prog Proc Am Soc Clin Oncol, 19, 44a

Maluf, 2000, Prog Proc Am Soc Clin Oncol, 19, 342a

Doyle, 2000, Prog Proc Am Soc Clin Oncol, 19, 424a

Campos, 2000, Prog Proc Am Soc Clin Oncol, 19, 401a

Manzione, 2000, Prog Proc Am Soc Clin Oncol, 19, 493a

Bouillet, 2000, Prog Proc Am Soc Clin Oncol, 19, 423a

Eckhardt, 2000, Prog Proc Am Soc Clin Oncol, 19, 420a

Lastra, 2000, Prog Proc Am Soc Clin Oncol, 19, 579a

Perez, 2000, Prog/Proc Am Soc Clin Oncol, 19, 114a

Bahri, 2000, Prog/Proc Am Soc Clin Oncol, 19, 422a

Feher, 2000, Prog/Proc Am Soc Clin Oncol, 19, 431a

Wang, 2000, Prog Proc Am Soc Clin Oncol, 19, 426a

Onat, 2000, Prog Proc Am Soc Clin Oncol, 19, 429a

D'Aiuto, 2000, Prog Proc Am Soc Clin Oncol, 19, 126a

Baltali, 2000, Prog Proc Am Soc Clin Oncol, 19, 121a

Deplanque, 2000, Prog Proc Am Soc Clin Oncol, 19, 104a

Budach, 2000, Prog Proc Am Soc Clin Oncol, 19, 418a

Denes, 2000, Prog Proc Am Soc Clin Oncol, 19, 212a

Gennari, 2000, Prog Proc Am Soc Clin Oncol, 19, 118a

Estevez, 2000, Prog Proc Am Soc Clin Oncol, 19, 199a

Constenla, 2000, Prog Proc Am Soc Clin Oncol, 19, 110a

Gomez, 2000, Prog Proc Am Soc Clin Oncol, 19, 108a

Teston, 2000, Prog Proc Am Soc Clin Oncol, 19, 134a

Chodkiewicz, 2000, Prog Proc Am Soc Clin Oncol, 19, 212a

Tubiana-Mathieu, 2000, Prog Proc Am Soc Clin Oncol, 19, 419a

Lara, 2000, Prog Proc Am Soc Clin Oncol, 19, 126a

Martinelli, 2000, Prog Proc Am Soc Clin Oncol, 19, 57a

Rein, 2000, Prog Proc Am Soc Clin Oncol, 19, 405a

Philip, 2000, Prog Proc Am Soc Clin Oncol, 19, 130a

Molitor, 2000, Prog Proc Am Soc Clin Oncol, 19, 398a

Vorobiof, 2000, Prog Proc Am Soc Clin Oncol, 19, 578a

Malik, 2000, Prog Proc Am Soc Clin Oncol, 19, 148a

Petrylak, 2000, Prog Proc Am Soc Clin Oncol, 19, 334a

Barroso, 2000, Prog Proc Am Soc Clin Oncol, 19, 144a

Spiridonidis, 2000, Prog Proc Am Soc Clin Oncol, 19, 503a

Brugnatelli, 2000, Prog Proc Am Soc Clin Oncol, 19, 156a

Paccagnella, 2000, Prog Proc Am Soc Clin Oncol, 19, 425a

Brancaccio, 2000, Prog Proc Am Soc Clin Oncol, 19, 541a

Rueda, 2000, Prog Proc Am Soc Clin Oncol, 19, 430a

Morelle, 2000, Prog Proc Am Soc Clin Oncol, 19, 428a

Van Cutsem, 2001, Prog Proc Am Soc Clin Oncol, 20, 131a

Stuart, 2001, Prog Proc Am Soc Clin Oncol, 20, 44b

Sobrero, 2001, Prog Proc Am Soc Clin Oncol, 20, 120b

Philip, 2001, Prog Proc Am Soc Clin Oncol, 20, 148b

Ostellino, 2001, Prog Proc Am Soc Clin Oncol, 20, 1216

Bazarbashi, 2001, Prog Proc Am Soc Clin Oncol, 20, 160a

González, 2001, Prog Proc Am Soc Clin Oncol, 20, 54b

Calvo, 2001, Prog Proc Am Soc Clin Oncol, 20, 136a

Lim, 2001, Prog Proc Am Soc Clin Oncol, 20, 114b

Ryan, 2001, Prog Proc Am Soc Clin Oncol, 20, 141a

Bruckner, 2001, Prog Proc Am Soc Clin Oncol, 20, 155a

Goubely-Brewer, 2001, Prog Proc Am Soc Clin Oncol, 20, 176

Machiavelli, 2001, Prog Proc Am Soc Clin Oncol, 20, 113b

Weekly cisplatin plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin (P-HDFL), a low-toxic and moderately active regimen, for advanced transitional cell carcinoma (TCC) [abstract 3128]. Available from URL: http://www.asco.org/ac/1,1003,_12-0022640-00_19-003128,00.asp [accessed March 5, 2004].

Destefanis, 2001, Prog Proc Am Soc Clin Oncol, 20, 119b

Goldstein, 2001, Prog Proc Am Soc Clin Oncol, 20, 145a

Arcuri, 2001, Prog Proc Am Soc Clin Oncol, 20, 190b

Leyvraz, 2001, Prog Proc Am Soc Clin Oncol, 20, 362a

Woll, 2001, Prog Proc Am Soc Clin Oncol, 20, 67b

Zambetti, 2001, Prog Proc Am Soc Clin Oncol, 20, 49b

Cortesi, 2001, Prog Proc Am Soc Clin Oncol, 20, 117b

Alonso, 2001, Prog Proc Am Soc Clin Oncol, 20, 110b

Villalon, 2001, Prog Proc Am Soc Clin Oncol, 20, 46b

Reid, 2001, Prog Proc Am Soc Clin Oncol, 20, 203b

Maoleekoonpairoj, 2001, Prog Proc Am Soc Clin Oncol, 20, 195b

Juturi, 2001, Prog Proc Am Soc Clin Oncol, 20, 366a

Wong, 2001, Prog Proc Am Soc Clin Oncol, 20, 198b

Chougule, 2001, Prog Proc Am Soc Clin Oncol, 20, 232a

Gonzalez-Cortijo, 2001, Prog Proc Am Soc Clin Oncol, 20, 203b

Brierley, 2001, Prog Proc Am Soc Clin Oncol, 20, 108b

Altundag, 2001, Prog Proc Am Soc Clin Oncol, 20, 205b

Leelasiri, 2001, Prog Proc Am Soc Clin Oncol, 20, 197b

Rischin, 2001, Prog Proc Am Soc Clin Oncol, 20, 227a

Meluch, 2001, Prog Proc Am Soc Clin Oncol, 20, 160a

Darby, 2001, Prog Proc Am Soc Clin Oncol, 20, 100b

Schrijvers, 2001, Prog Proc Am Soc Clin Oncol, 20, 198b

Pescia, 2001, Prog Proc Am Soc Clin Oncol, 20, 47b

Gomez-Bernal, 2001, Prog Proc Am Soc Clin Oncol, 20, 52b

Borrega, 2001, Prog Proc Am Soc Clin Oncol, 20, 33b

Tonkin, 2001, Prog Proc Am Soc Clin Oncol, 20, 67b

Pribylova, 2001, Prog Proc Am Soc Clin Oncol, 20, 65b

Firvida, 2001, Prog Proc Am Soc Clin Oncol, 20, 269b

Jagiello-Geuszfield, 2001, Prog Proc Am Soc Clin Oncol, 20, 42b

Lizon, 2001, Prog Proc Am Soc Clin Oncol, 20, 270b

Tishler, 2001, Prog Proc Am Soc Clin Oncol, 20, 233a

Neis, 2001, Prog/Proc Am Soc Clin Oncol, 20, 45b

Menendez, 2001, Prog Proc Am Soc Clin Oncol, 20, 256b

Perez Manga, 2001, Prog Proc Am Soc Clin Oncol, 20, 65b

Bergmann, 2001, Prog Proc Am Soc Clin Oncol, 20, 302a

Fernandez-Rodriguez, 2001, Prog Proc Am Soc Clin Oncol, 20, 283b

Buddharaju, 2001, Prog Proc Am Soc Clin Oncol, 20, 302a

Berretta, 2001, Prog Proc Am Soc Clin Oncol, 20, 111b

Tsuji, 2001, Prog Proc Am Soc Clin Oncol, 20, 150b

Ravaioli, 2001, Prog Proc Am Soc Clin Oncol, 20, 121b

Salgado, 2001, Prog Proc Am Soc Clin Oncol, 20, 114b

Innes, 2001, Prog Proc Am Soc Clin Oncol, 20, 107b

Collichio, 2001, Prog Proc Am Soc Clin Oncol, 20, 71b

Grothey, 2001, Prog Proc Am Soc Clin Oncol, 20, 125a

Mehta, 2001, Prog Proc Am Soc Clin Oncol, 20, 148a

Caro, 2001, Prog Proc Am Soc Clin Oncol, 20, 109b

Artu, 2001, Prog Proc Am Soc Clin Oncol, 20, 164a

Andre, 2001, Prog Proc Am Soc Clin Oncol, 20, 155a

Kuhn, 2001, Prog Proc Am Soc Clin Oncol, 20, 130b

Kinoshita, 2001, Prog Proc Am Soc Clin Oncol, 20, 266b

Lopez-Vivanco, 2001, Prog Proc Am Soc Clin Oncol, 20, 268b

Brandi, 2001, Prog Proc Am Soc Clin Oncol, 20, 52b

Gonzalez de Sande, 2001, Prog Proc Am Soc Clin Oncol, 20, 221a

Park, 2001, Prog Proc Am Soc Clin Oncol, 20, 47a

Ferrari, 2001, Prog Proc Am Soc Clin Oncol, 20, 259b

Chen, 2001, Prog Proc Am Soc Clin Oncol, 20, 340a

Sanchez Rovira, 2001, Prog Proc Am Soc Clin Oncol, 20, 31b

Merlano, 2001, Prog Proc Am Soc Clin Oncol, 20, 196b

Rosen, 2001, Prog Proc Am Soc Clin Oncol, 20, 226a

Battelli, 2001, Prog Proc Am Soc Clin Oncol, 20, 27b

Hartmann, 2001, Prog Proc Am Soc Clin Oncol, 20, 173a

Bretti, 2001, Prog Proc Am Soc Clin Oncol, 20, 52b

Adelstein, 2001, Prog Proc Am Soc Clin Oncol, 20, 224a

Mantovani, 2001, Prog Proc Am Soc Clin Oncol, 20, 237b

Reece, 2001, Prog Proc Am Soc Clin Oncol, 20, 15a

Giles, 2001, Prog Proc Am Soc Clin Oncol, 20, 287a

Azzoli, 2001, Prog Proc Am Soc Clin Oncol, 20, 331a

Murad, 2001, Prog Proc Am Soc Clin Oncol, 20, 109b

Domenech, 2001, Prog Proc Am Soc Clin Oncol, 20, 48b

Cortes, 2001, Prog Proc Am Soc Clin Oncol, 20, 304a

Wang, 1996, J Surg Oncol, 62, 22, 10.1002/(SICI)1096-9098(199605)62:1<22::AID-JSO5>3.0.CO;2-T

Afonso-Afonso, 2000, Prog Proc Am Soc Clin Oncol, 19, 301a

Papadimitrakopoulou, 2000, Prog Proc Am Soc Clin Oncol, 19, 420a

Benasso, 2000, Prog Proc Am Soc Clin Oncol, 19, 413a

Kozuch, 2001, Prog Proc Am Soc Clin Oncol, 20, 155a

Fyles, 1992, Radiother Oncol, 25, 273, 10.1016/0167-8140(92)90247-R

Yeoh, 1993, Am J Med, 95, 397, 10.1016/0002-9343(93)90309-D

Yeoh, 1996, Int J Radiat Oncol Biol Phys, 35, 1003, 10.1016/0360-3016(96)00147-2

Husebye, 1995, Gastroenterology, 109, 1078, 10.1016/0016-5085(95)90565-0

Husebye, 1994, Digest Dis Sci, 39, 2341, 10.1007/BF02087648

Hauer-Jensen, 1995, Digest Dis Sci, 40, 2170, 10.1007/BF02209001

Thông tin
Thông tin xuất bản

Cancer

Tập 100 Số S9

1995-2025

Thông tin tác giả